Background Individual malaria interventions provide only partial protection in most
epidemiological situations. Thus, there is a need to investigate whether combining …

Objectives To compare the efficacy and safety of artemether-lumefantrine (AL) and
dihydroartemisinin-piperaquine (DP) for treating uncomplicated falciparum malaria in …

Malaria is one of the most significant causes of morbidity and mortality worldwide. Every
year, nearly one million deaths result from malaria infection. Malaria can be controlled in …

Abstract Background The World Health Organization recommends artemisinin-based
combination (ACT) for the treatment of uncomplicated malaria. Post-licensure safety data on …

Adherence to artemisinin‐based combination therapy (ACT) is not clearly defined. This meta‐
analysis determines the prevalence and predictors of adherence to ACT. Twenty‐five …

Background Several studies have reported high efficacy and safety of artemisinin-based
combination therapy (ACT) mostly under strict supervision of drug intake and limited to …

Background Artemisinin combination therapies (ACTs) are currently the preferred option for
treating uncomplicated malaria. Dihydroartemisinin-piperaquine (DHA-PQP) is a promising …

Background Presented here are the results of a comparative trial on the efficacy of three
artemisinin-based combinations conducted from May to October 2004, in Pool Province …

Background As a result of rising levels of drug resistance to conventional monotherapy, the
World Health Organization (WHO) and other international organisations have recommended …

Since 2004, WHO has promoted strategies for improving access to treatment through home
management of malaria, in order to ensure prompt diagnosis and effective treatment for …